Clinical Trials Browser

Phase 3 × Epstein-Barr Virus Infections × Epirubicin × Clear all

NCT02363400 2025-08-19

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

Phase 3 Terminated

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections